CICLOSPORIN 0.1% EYE DROPS (Vevizye®)

Clinical Indication

Treatment of moderate-to-severe Dry Eye Disease

Comments

Alternative if Cequa® not tolerated

Specialist ophthalmologist initiation for use in line with NICE TA 369 only for treating severe keratitis in adult patients with dry eye disease that has not improved despite treatment with tear substitutes. Prescribe by brand.

Cetalkonium chloride free formulation.

Date of classification

July 2026

Yellow

Specialist recommendation: Medicines initiated (and stabilised where appropriate) or recommended by a specialist service for prescribing in primary care. Requests should be clearly communicated either through written communication including using approved paperwork if available or verbal means as appropriate .